Wilhelmus Groenhuysen

2021

In 2021, Wilhelmus Groenhuysen earned a total compensation of $6.4M as Chief Operating Officer at NovoCure, a 8% decrease compared to previous year.

Compensation breakdown

Option Awards$1,914,408
Salary$615,000
Stock Awards$3,833,245
Other$24,308
Total$6,386,961

Groenhuysen received $3.8M in stock awards, accounting for 60% of the total pay in 2021.

Groenhuysen also received $1.9M in option awards, $615K in salary and $24.3K in other compensation.

Rankings

In 2021, Wilhelmus Groenhuysen's compensation ranked 1,991st out of 12,405 executives tracked by ExecPay. In other words, Groenhuysen earned more than 84.0% of executives.

ClassificationRankingPercentile
All
1,991
out of 12,405
84th
Division
Manufacturing
756
out of 5,494
86th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
79
out of 798
90th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
50
out of 519
90th
Industry
Surgical and Medical Instruments and Apparatus
33
out of 324
90th
Source: SEC filing on April 25, 2022.

Groenhuysen's colleagues

We found four more compensation records of executives who worked with Wilhelmus Groenhuysen at NovoCure in 2021.

2021

Pritesh Shah

NovoCure

Chief Commercial Officer

2021

Ashley Cordova

NovoCure

Chief Financial Officer

2021

Todd Longsworth

NovoCure

General Counsel

2021

Asaf Danziger

NovoCure

Chief Executive Officer

News

You may also like